LONDON (Reuters) – GlaxoSmithKline Plc (), Britain’s biggest drugmaker, faces more top management change with Chief Financial Officer Simon Dingemans set to retire next year. The former Goldman Sachs () investment banker, who joined in 2011, will step down from the board in May 2019, the company said on Wednesday.
Name: Simon Dingemans
Company: GlaxoSmithKline Plc
Announcement Date: May 08, 2018, 10:00pm
Resignation Date: May 08, 2018, 10:00pm